PRECIGEN, INC.
For the period ended Dec 31, 2024. Filed Mar 19, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 19, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: March 19, 2025
| PRECIGEN, INC. | |
|---|---|
| By: | /S/ HELEN SABZEVARI |
| Helen SabzevariChief Executive Officer and Director | |
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /S/ HELEN SABZEVARI | Chief Executive Officer and Director(Principal Executive Officer) | 3/19/2025 |
| Helen Sabzevari | ||
| /S/ HARRY THOMASIAN JR. | Chief Financial Officer(Principal Accounting and Financial Officer) | 3/19/2025 |
| Harry Thomasian Jr. | ||
| /S/ RANDAL J. KIRK | Executive Chairman | 3/19/2025 |
| Randal J. Kirk | ||
| /S/ NANCY H. AGEE | Director | 3/19/2025 |
| Nancy H. Agee | ||
| /S/ CESAR L. ALVAREZ | Director | 3/19/2025 |
| Cesar L. Alvarez | ||
| /S/ STEVEN FRANK | Director | 3/19/2025 |
| Steven Frank | ||
| /S/ VINITA D. GUPTA | Director | 3/19/2025 |
| Vinita D. Gupta | ||
| /S/ FRED HASSAN | Director | 3/19/2025 |
| Fred Hassan | ||
| /S/ JEFFREY B. KINDLER | Director | 3/19/2025 |
| Jeffrey B. Kindler | ||
| /S/ JAMES S. TURLEY | Director | 3/19/2025 |
| James S. Turley | ||
Index to the Financial Statements and Schedules
| Page(s) | |
| Consolidated Financial Statements of Precigen, Inc. and Subsidiaries | F-2 |
|---|---|
| Report of Independent Registered Public Accounting Firm (PCAOB ID No. 34) | F-3 |
| Consolidated Balance Sheets as of December 31, 2024 and 2023 | F-5 |
| Consolidated Statements of Operations for the Years Ended December 31, 2024, 2023, and 2022 | F-7 |
| Consolidated Statements of Comprehensive (Loss) Income for the Years Ended December 31, 2024, 2023, and 2022 | F-8 |
| Consolidated Statements of Mezzanine Equity and Shareholders' and Total Equity for the Years Ended December 31, 2024, 2023, and 2022 | F-9 |
| Consolidated Statements of Cash Flows for the Years Ended December 31, 2024, 2023, and 2022 | F-12 |
| Notes to the Consolidated Financial Statements | F-15 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.